| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3199 |
| Trial ID | NCT05570188 |
| Disease | B-Cell Lymphoma | B-Cell Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 UCAR-NK cells |
| Co-treatment | HSCT |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies |
| Year | 2022 |
| Country | China |
| Company sponsor | Kunming Hope of Health Hospital |
| Other ID(s) | PBC042 |
| Cohort 1 | |||||||||||
|
|||||||||||